Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 13,334 shares at $20.10 ($268K) on 2025-10-07, disclosed to the SEC on 2025-10-09.
Scheduled sale ($268k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.10 | 6,667 | $134K | 50.0% |
| 2 | $20.10 | 6,667 | $134K | 50.0% |
| Total | $20.10 avg | 13,334 | $268K | 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |
| ELVN | SELL | 2025-08-11 | $236K | — | Filing → |